Nanolattix Biotechnology Co., Ltd.
Nanolattix Biotechnology Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors | Solid Tumors | Recruiting | Early phase 1 | 2026-04-01 | NCT07505069 | |
| Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors | Advanced Solid Tumor (Phase 1) | Not yet recruiting | Phase 1 | 2026-02-25 | NCT07434609 |